Heron Therapeutics Inc (HRTX)
2.96
+0.05
(+1.72%)
USD |
NASDAQ |
Apr 15, 16:00
2.96
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Total Assets (Quarterly): 222.51M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 222.51M |
| September 30, 2023 | 229.20M |
| June 30, 2023 | 201.22M |
| March 31, 2023 | 220.88M |
| December 31, 2022 | 250.95M |
| September 30, 2022 | 271.95M |
| June 30, 2022 | 243.96M |
| March 31, 2022 | 273.72M |
| December 31, 2021 | 305.71M |
| September 30, 2021 | 352.39M |
| June 30, 2021 | 404.25M |
| March 31, 2021 | 310.93M |
| December 31, 2020 | 353.56M |
| September 30, 2020 | 390.02M |
| June 30, 2020 | 432.72M |
| March 31, 2020 | 478.94M |
| December 31, 2019 | 512.78M |
| September 30, 2019 | 392.96M |
| June 30, 2019 | 411.67M |
| March 31, 2019 | 435.79M |
| December 31, 2018 | 462.18M |
| September 30, 2018 | 470.90M |
| June 30, 2018 | 510.56M |
| March 31, 2018 | 183.38M |
| December 31, 2017 | 234.31M |
| Date | Value |
|---|---|
| September 30, 2017 | 118.20M |
| June 30, 2017 | 142.37M |
| March 31, 2017 | 189.56M |
| December 31, 2016 | 67.48M |
| September 30, 2016 | 98.81M |
| June 30, 2016 | 85.73M |
| March 31, 2016 | 111.85M |
| December 31, 2015 | 137.84M |
| September 30, 2015 | 158.15M |
| June 30, 2015 | 176.46M |
| March 31, 2015 | 59.63M |
| December 31, 2014 | 76.68M |
| September 30, 2014 | 92.28M |
| June 30, 2014 | 108.64M |
| March 31, 2014 | 62.79M |
| December 31, 2013 | 75.94M |
| September 30, 2013 | 26.37M |
| June 30, 2013 | 38.09M |
| March 31, 2013 | 48.98M |
| December 31, 2012 | 55.97M |
| September 30, 2012 | 61.76M |
| June 30, 2012 | 14.23M |
| March 31, 2012 | 14.99M |
| December 31, 2011 | 19.44M |
| September 30, 2011 | 21.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
201.22M
Minimum
Jun 2023
512.78M
Maximum
Dec 2019
329.49M
Average
310.93M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| United Therapeutics Corp | 7.167B |
| Esperion Therapeutics Inc | 205.80M |
| Aldeyra Therapeutics Inc | 148.33M |
| Macrogenics Inc | 298.42M |
| Ocular Therapeutix Inc | 252.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 256.48M |
| Shareholders Equity (Quarterly) | -33.97M |
| Debt to Equity Ratio | -5.114 |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | -1.92% |